Opinion

Video

Impact of Off-Target AEs and Treatment Resistance on Evolving 1L Therapy Strategies for CLL

Javier Pinilla, MD, PhD, provides a brief overview of the changing CLL treatment landscape, discussing the influence of off-target adverse events and the development of treatment resistance on the evolution of BTK inhibitor therapy.

Video Player is loading.
Current Time 0:00
Duration 2:35
Loaded: 0%
Stream Type LIVE
Remaining Time 2:35
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected